[Intellectual disability: is the new denomination a shift in perspective?].

Vertex

Centro Interdisciplinario de Atención en Salud Mental. Centro Educativo Terapéutico C.A.I.T.I.

Published: September 2014

The change from "mental retardation" to "intellectual disability" (ID) in the new version of the DSM-5 aims not only to eliminate stigmatization but also to modify diagnostic criteria. The IQ is no longer preeminent for defining ID or its severity, relying instead on broader clinical criteria and neuropsychological evaluation. More relevance is given to the evaluation of the individual's performance on daily life. This perspective addresses the concerns raised since the 1990's by organizations representing professionals and patients and their families. To better understand these changes we reviewed the definitions and criteria of previous DSM editions. The adoption of the alternative denomination of the "intellectual developmental disorder" is compatible with the ICD-11 to be released in 2015. This guideline was based on the recommendation of the working group for the classification of the intellectual disabilities.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[intellectual disability
4
disability denomination
4
denomination shift
4
shift perspective?]
4
perspective?] change
4
change "mental
4
"mental retardation"
4
retardation" "intellectual
4
"intellectual disability"
4
disability" version
4

Similar Publications

Background: The current literature has established that prejudice in child protection cases with parents with intellectual disabilities continues to persist. However, complexities of these cases are not well-understood from the perspective of child protection workers. This study aimed to identify the needs of child protection workers and their views on factors that influence supports for parents with intellectual disabilities.

View Article and Find Full Text PDF

Morbidities and comorbidities associated with optic nerve hypoplasia and septo-optic-pituitary dysplasia.

Dev Med Child Neurol

January 2025

Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Aim: To quantify optic nerve hypoplasia (ONH) and septo-optic-pituitary dysplasia (SOD) morbidities and comorbidities.

Method: A retrospective population-based study with a case-control design was undertaken using administrative health data from Manitoba, Canada. Cases were 124 patients with ONH or SOD (70 males, 54 females; age range 6 months-36 years 8 months [mean 13 years, SD 7 years 2 months]) diagnosed from 1990 to 2019, matched to 620 unrelated population-based controls (350 males, 270 females; age range 0-36 years 8 months [mean 12 years 5 months, SD 7 years 2 months]) on birth year, sex, and area of residence.

View Article and Find Full Text PDF

Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the gene, potentially disrupting lipid metabolism and leading to dyslipidemia (DLD) and steatotic liver disease (SLD). Although SLD has been described in RTT mouse models, it remains undocumented in humans. We herein describe a 24-year-old woman with RTT who was evaluated for abnormal liver enzymes.

View Article and Find Full Text PDF

Genetics of Prader-Willi and Angelman syndromes: 2024 update.

Curr Opin Psychiatry

December 2024

Departments of Psychiatry &, Behavioral Sciences and Pediatrics, University of Kansas Medical Centre, Kansas City, Kansas, United States.

Purpose Of Review: Prader-Willi (PWS) and Angelman (AS) syndromes arise from errors in 15q11-q13 imprinting. This review describes recent advances in genomics and how these expand our understanding of these rare disorders, guiding treatment strategies to improve patient outcomes.

Recent Findings: PWS features include severe infantile hypotonia, failure to thrive, hypogonadism, developmental delay, behavioral and psychiatric features, hyperphagia, and morbid obesity, if unmanaged.

View Article and Find Full Text PDF

Super-refractory status epilepticus (SRSE) is defined as status epilepticus that persists or recurs after treatment with anesthetic agents for more than 24 hours, including cases with recurrent seizures on reduction or withdrawal of anesthetic drugs. Super-refractory status epilepticus presents a significant challenge for neurologists, particularly when standard treatments fail to achieve seizure control. Lacosamide, which has a unique mechanism involving modulating voltage-gated sodium channels by enhancing their slow inactivation, has emerged as a potential option for managing SRSE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!